AOD-9604 Side Effects: Safety Signals and Warnings
AOD-9604 safety concerns are compound-specific. The main listed side effects are Injection site irritation, Headache, and Mild nausea. The main warning signals are Not FDA approved for any indication, Human clinical trials for obesity did not meet primary endpoints, and Quality and purity of research-grade peptides may vary significantly.
Direct Answer
Evidence for AOD-9604 is too preliminary to support a research protocol with confidence. The compound's Phase 3 trial failed on the primary endpoint, returning negative efficacy data for weight loss in humans. Of the Weight Loss & Metabolic compounds in this library, semaglutide, tirzepatide, or retatrutide have vastly stronger evidence bases as starting points.
- Evidence grade
- Level D
- Research status
- Preclinical
- Category
- Weight Loss & Metabolic
- Best for
- No validated human application - mechanistic lipolysis research only
Reported Side Effects
- Injection site irritation
- Headache
- Mild nausea
- Fatigue
Warnings
- Not FDA approved for any indication
- Human clinical trials for obesity did not meet primary endpoints
- Quality and purity of research-grade peptides may vary significantly
- Banned by WADA in competitive sports
Known or Plausible Interactions
- Growth hormone (may compete for similar downstream pathways)
- Beta-3 adrenergic agonists (potential additive effects)
Regulatory Context
Not FDA approved. Available as a research chemical in some jurisdictions. GRAS status granted by FDA for use in food supplements in specific contexts. Banned by WADA.
Evidence Snapshot
| Evidence grade | Level D |
|---|---|
| Research status | Preclinical |
| Best supported outcomes | Fat Mass Reduction (Level D) and Cartilage Repair (Level D) |
| Primary citation count | 2 |
| Last reviewed | 2026-06-02 |
Related Guides
How to Cite This Page
ExaminePeptides. "AOD-9604 Side Effects: Safety Signals and Warnings." Last reviewed 2026-06-02. https://examinepeptides.com/answers/aod-9604-side-effects-safety/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.